Search | Vaccinex, Inc.

Filter by content type

Filter by year

Vaccinex Presented its ActivMAb® Antibody Discovery Technology at the 2014 PEGS Europe Summit

Vaccinex Presented data on VX15/2503 at American Society of Clinical Oncology (ASCO) 2014 Conference

Vaccinex Appoints Steve Cobourn, C.P.A. as Chief Financial Officer

Vaccinex Presented data on VX15/2503 at CRI Cancer Immunotherapy 2013 Conference

Vaccinex Presented VX15 Preclinical MS Data at the 2013 ECTRIMS Annual Conference

Vaccinex Appoints Valerie Iddison, M.D. as Chief Medical Officer

Vaccinex, Inc. Announces Initiation of a Phase 1 Clinical Trial of VX15/2503 Antibody in Multiple Sclerosis Patients

Vaccinex Presented Antibody Selection Technology at the 2012 IBC Antibody Engineering and Antibody Therapeutics Conference

Vaccinex to Present VX15 and VX5 Preclinical MS Data at the 2012 ECTRIMS Annual Conference

Vaccinex Presented at the American Association for Cancer Research (AACR) Annual Conference